Cargando…
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients
Multiple sclerosis (MS) is a complex neurological disease where, in genetically predisposed individuals, the unbalanced interplay between pathogenic and regulatory T cells will result in the progression of the autoimmune assault to neural antigens. Fingolimod (FTY720), an oral sphingosine 1-phosphat...
Autores principales: | Serpero, Laura D., Filaci, Gilberto, Parodi, Alessia, Battaglia, Florinda, Kalli, Francesca, Brogi, Davide, Mancardi, Giovanni Luigi, Uccelli, Antonio, Fenoglio, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889247/ https://www.ncbi.nlm.nih.gov/pubmed/23649711 http://dx.doi.org/10.1007/s11481-013-9465-5 |
Ejemplares similares
-
Phenotypic Alterations Involved in CD8+ Treg Impairment in Systemic Sclerosis
por: Negrini, Simone, et al.
Publicado: (2017) -
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
por: Novi, Giovanni, et al.
Publicado: (2017) -
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial
por: Laroni, Alice, et al.
Publicado: (2014) -
Different MRI patterns in MS worsening after stopping fingolimod
por: Lapucci, Caterina, et al.
Publicado: (2019) -
Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice
por: Kalli, Francesca, et al.
Publicado: (2013)